中国药物警戒 ›› 2010, Vol. 7 ›› Issue (2): 100-102.

• 管理研究 • 上一篇    下一篇

我国药品不良反应损害救济风险分担机制研究

王华, 杨悦   

  1. 沈阳药科大学工商管理学院,辽宁 沈阳 110016
  • 收稿日期:2016-02-19 修回日期:2016-02-19 出版日期:2010-02-08 发布日期:2016-02-19
  • 通讯作者: 杨悦,女,副教授,药事法规与药品政策。E-mail：yyue315@126.com
  • 作者简介:王华,女,在读硕士,药事法规与药品政策。

Study on Adverse Drug Reaction Damage Relief Risk Sharing Mechanism in China

WANG Hua, YANG Yue*   

  1. College of Business Administration, Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China
  • Received:2016-02-19 Revised:2016-02-19 Online:2010-02-08 Published:2016-02-19

PDF (PC)

175

摘要： 目的 探索完善我国药品不良反应损害救济风险分担机制的方法。方法 采用文献研究方法、比较研究方法,描述我国现行法律关于药品不良反应损害赔偿的问题,通过借鉴国外和我国台湾地区药品不良反应损害救济制度,提出完善我国药品不良反应损害救济风险分担机制的建议。结果 与结论 侵权责任方面,我国产品缺陷界定存在不足,应加以完善;专门救济方面,我国应通过药品不良反应损害责任保险和药品不良反应损害救济基金分担药品不良反应损害风险。

关键词: 药品不良反应, 侵权责任, 专门救济

Abstract: Objective To explore the ways to consummate the adverse drug reaction（ADR） damage relief risk sharing mechanism in our country. Methods Using literature and comparative method, we analyzed the present situation of the current legal regulations on ADR damage relief and put forward some suggestions on the improvement of the existing ADR damage relief risk sharing mechanism by referring to ADR damage relief system of Taiwan and foreign countries. Results & Conclusion Our existing tort liability has problem in product flaw limits and we should con-summate through this aspect. We should also share ADR damage risks through ADR liability insurance and ADR damage relief foundation from the ADR special relief aspect.

Key words: adverse drug reaction(ADR), tort liability, special relief

中图分类号: